Molecular pathogenesis of human hepatocellular carcinoma.
about
ARID2: a new tumor suppressor gene in hepatocellular carcinomaAflatoxin: a 50-year odyssey of mechanistic and translational toxicologyTargeting Hepatocellular Carcinoma: What did we Discover so Far?Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic interventionDecreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinomaHepatitis C virus and hepatocarcinogenesisPromoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCsScreening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysisMALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma.Molecular genetics of hepatocellular neoplasia.SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replicationCooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line.The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Clinical implications of cancer stem cell biology in hepatocellular carcinoma.Oncolytic herpes viral therapy is effective in the treatment of hepatocellular carcinoma cell lines.Epidemiology of primary and secondary liver cancers.Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.Monitoring microarray-based gene expression profile changes in hepatocellular carcinomaPredictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression.TP53 mutations in workers exposed to occupational carcinogens.Fucoidan induces apoptosis of HepG2 cells by down-regulating p-Stat3.Targeted therapy in hepatocellular carcinomaHepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis.Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysisThe mitochondrial DNA 9-bp deletion polymorphism is a risk factor for hepatocellular carcinoma in the Chinese population.Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma.Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma.Chemopreventive effect of selenium and Chinese medicinal herbs on N-nitrosobis(2-oxopropyl)amine-induced hepatocellular carcinoma in Syrian hamsters.Bioinformatics analysis of the gene expression profile of hepatocellular carcinoma: preliminary results.Future of molecular profiling of human hepatocellular carcinoma.MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression.Specific mutations of hepatitis B virus in plasma predict liver cancer development.Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteineAntihepatoma and liver protective potentials of ganoderma lucidum ( ling zhi) fermented in a medium containing black soybean ( hēi dòu) and astragalus membranaceus ( shēng huáng qí).Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
P2860
Q24607045-125BF423-8A95-4822-8080-DDF5DFE9EA40Q24617120-ED8B2686-9618-4815-B246-EEC1D95A9316Q28077283-4E92F8AB-9F76-4888-A09B-7308ED88355AQ28080281-DE637A54-281F-42D1-9DA9-0A94B40B45D9Q28237677-3E95F508-B1A5-4111-81FC-4EEB06E21FAEQ28283484-D35D8C9E-DAAF-45C0-AC34-B2F599E9F1A1Q28305454-80F916A8-CB06-4D6D-97B8-166FFCAB77BBQ33321107-9D3879C2-A873-46CD-B21A-0FEFCED2DDE6Q33641007-864E7C7A-031F-4332-86E9-870E2A59FD76Q33680701-5189B236-43DE-4033-8B06-E0FFA26A8704Q33689008-9F7A80D3-525A-4B69-B5E9-AB30A0952B17Q33867835-95651DF9-0248-4392-B60D-78DE6D138054Q34177169-AA59A773-2B52-4987-8D2F-D5FA42DE1068Q34182483-67A7805D-0355-4152-A745-8CDE3AA4C992Q34357073-8EE8D0F3-2ED6-4355-9EE7-AAA91623FEF7Q34557399-355DC4DF-7815-4280-A4D3-D21235C6C03DQ34563350-15B5EEBE-294E-475D-BAE3-4EFAE09D1ED0Q34765478-35B994F1-A035-4EAA-AA5F-CE5804C4469EQ35011295-D94CA0D8-1F4B-4D95-A0A1-2D1846163055Q35020474-A971B7FC-1E4C-4377-A37A-AF02503F7239Q35025037-6912EFBF-E82F-4109-B615-166DF58F0CE0Q35078737-89D807DB-676F-458E-8B2C-E432C7723217Q35190023-8297C042-25FF-4968-825A-FCDA0D6A65AEQ35207561-372D71CE-F177-4BF6-923D-82601D24FA27Q35882733-98C1D1B4-B3AC-411F-9D9C-5476284DAF53Q35942016-8B12A6AA-A4FD-41AE-90A4-410BC3FA23AEQ35966991-12B69E48-EB49-4CE7-932C-7E9E8F71D7E4Q36070462-135D5D11-E182-4908-B4DD-69F121175B30Q36313998-5AE381E8-42B5-4B4A-A58B-A4218D3D6712Q36318656-C526AC38-3E01-4F6F-883D-6DFD9F7B295BQ36695216-4310DB00-F300-48B3-BF9D-F9C688707D8FQ36737425-A515A697-D28C-4901-84C8-3BF1972853BEQ36792873-CFEA1D03-E7C1-4C8C-BE9F-69CC9D1579C9Q36895812-2A4D7AB8-82AD-494B-9451-9B2C86618535Q37010976-BF89E691-4F7B-4880-85DE-35844ED5AAC1Q37074286-CDDFD9EE-147F-4987-BE89-3B9CAD6E883CQ37209229-B7608461-5445-466E-BD0D-68E0D7F36318Q37585302-C65390F7-B587-4F47-92C0-95B9C6CA57D3Q37800793-F9295AAD-9973-494F-909B-A1AFAEF3E10EQ37858630-6723C098-FF33-48C7-8A40-1DE174523AAA
P2860
Molecular pathogenesis of human hepatocellular carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Molecular pathogenesis of human hepatocellular carcinoma.
@ast
Molecular pathogenesis of human hepatocellular carcinoma.
@en
Molecular pathogenesis of human hepatocellular carcinoma.
@nl
type
label
Molecular pathogenesis of human hepatocellular carcinoma.
@ast
Molecular pathogenesis of human hepatocellular carcinoma.
@en
Molecular pathogenesis of human hepatocellular carcinoma.
@nl
prefLabel
Molecular pathogenesis of human hepatocellular carcinoma.
@ast
Molecular pathogenesis of human hepatocellular carcinoma.
@en
Molecular pathogenesis of human hepatocellular carcinoma.
@nl
P2093
P1433
P1476
Molecular pathogenesis of human hepatocellular carcinoma
@en
P2093
Christian Brechot
Chuan-Ging Wu
Curtis C Harris
Lorne J Hofseth
Marshonna Forgues
Teh-Ia Huo
Xin W Wang
P356
10.1016/S0300-483X(02)00253-6
P407
P478
P50
P577
2002-12-01T00:00:00Z